ROR1-Specific Chimeric Antigen Receptor (CAR) NK Cells As a Potential Therapy for High Risk Sarcomas and Neuroblastomas

Authors

Hae In Park, New York Medical CollegeFollow
A Awasthi
J AyelloFollow
Yaya Chu, New York Medical CollegeFollow
Jeremy Rosenblum, New York Medical CollegeFollow
D LeeFollow
Mitchell Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

June 2017

Journal Title

Pediatric Blood & Cancer

Department

Pediatrics

Second Department

Epidemiology and Community Health

Recommended Citation

Park, H., Awasthi, A., Ayello, J., Chu, Y., Rosenblum, J., Lee, D., & Cairo, M. (2017). ROR1-Specific Chimeric Antigen Receptor (CAR) NK Cells As a Potential Therapy for High Risk Sarcomas and Neuroblastomas. Pediatric Blood & Cancer, 64 (Suppl 1), S100. Retrieved from https://touroscholar.touro.edu/nymc_fac_abstracts/113